Blocking the GLP-1 receptor with exendin(9-39) eliminates the improvements in insulin sensitivity and blood glucose control that result from liraglutide treatment in people with obesity and...

In people with obesity and prediabetes, the drug liraglutide lowers blood glucose levels after fasting and after meals within two weeks, even without weight loss. This effect is not seen with other approaches that increase GLP-1 naturally or reduce calories, suggesting liraglutide works through a distinct mechanism.

In people with obesity and prediabetes, a daily dose of liraglutide improves how the body responds to insulin within two weeks, before any significant weight loss occurs, and this improvement is blocked when the GLP-1 receptor is inhibited.

In people with obesity and prediabetes, a drug called sitagliptin increases certain gut hormones but does not improve how the body responds to insulin or lower fasting blood sugar. This suggests that simply boosting these natural hormones is not enough—direct pharmacological activation of their receptors is needed for metabolic improvement.

A substance called Exendin-4 works like a longer-lasting version of a natural hormone in your body that helps control blood sugar, so it might help people with type 2 diabetes manage their glucose levels better.

Some diabetes drugs like liraglutide and semaglutide might help pregnant women with blood sugar problems by lowering their blood sugar levels and improving how their body handles insulin.